Human iPSC-derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntington's disease mouse model.

Intracerebral Transplants of GMP-Grade Human Umbilical Cord-Derived Mesenchymal Stromal Cells Effectively Treat Subacute-Phase Ischemic Stroke in a Rodent Model.

Neural Transplants From Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington’s Disease.

Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington’s disease.

Cell Proliferation ORIGINAL ARTICLE Open Access Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington’s disease.

Modeling of Frontotemporal Dementia Using iPSC Technology.

Intracerebral transplantation of HLA-homozygous human iPSC-derived neural precursors ameliorates the behavioural and pathological deficits in a rodent model of ischaemic stroke.

Intracerebral transplantation of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) promotes migration, differentiation, and functional recovery in a rodent model of Huntington's disease.

Implantation of the clinical-grade human neural stem cell line, CTXoEo3, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease.

Multimodal therapeutic effects of neural precursor cells derived from human induced pluripotent stem cells through episomal plasmid-based reprogramming in a rodent model of ischemic stroke.

Screening method for candidate drugs for Huntington's disease using induced pluripotent stem cells derived from Huntington's disease patients. (101535253)

Pharmaceutical composition for the treatment of stroke comprising neural precursor cells derived from human induced pluripotent stem cells. (101516352)